PCR Markets for Life Sciences Applications 2017-2022

Dublin, April 18, 2018 -- The "PCR Markets for Life Sciences Applications (Market by Type - qPCR, dPCR - Application - Pharmaceutical, General Research, and by Country and Region)" report has been added to ResearchAndMarkets.com's offering.

What is the size of the market for PCR (polymerase chain reaction) technologies used in life sciences?

Including instruments, reagents, other consumables and software and services related to instruments, the market exceeds $2 billion dollars. This market is smaller than the clinical / diagnostics applications, but life science applications of PCR form an important basis for sales.

As part of its coverage of this market, the report provides:

• The Market for Life Sciences PCR, 2017 to 2022
• Application Market Segmentation of Pharmaceutical and General Medical Research
• Market Segmentation of qPCR and dPCR markets, 2017-2022
• United States Life Sciences PCR Market, 2017-2022
• European Life Sciences PCR Market, 2017-2022
• Japanese Market for Life Sciences PCR, 2017-2022
• China Market for Life Sciences PCR, 2017-2022
• LATAM Market for Life Sciences PCR, 2017-2022
• Rest of World Market for Life Sciences PCR, 2017-2022

The life science market for PCR grew steadily for over two decades, although this growth is leveling off now. This is a large, diverse market that is now facing competition from next generation sequencing for a number of applications.

PCR technology has been widely licensed to other companies for both life science (for the purposes of this report, the research market equals the life science market) and diagnostic applications, and many companies are now active in these fields. Real-time PCR (qPCR) has become the most widely used DNA amplification method today.

PCR was the first of what are now many nucleic acid amplification test (PCR) methods that have been developed and commercialized. Examples of isothermal PCRs include loop mediated isothermal amplification (LAMP), nicking enzyme amplification reaction (NEAR), strand displacement amplification (SDA), nucleic acid sequence based amplification (NASBA) and transcription-mediated amplification (TMA).

Isothermal PCRs have been developed that can provide results more quickly than qPCR, sometimes in less than 30 minutes. Reduced equipment requirements, simpler workflows, and applicability to sample-to-answer platforms make isothermal methods ideal for decentralized and point-of-care molecular diagnostics. Both isothermal PCR and qPCR technologies are being applied to point-of-care and near-patient molecular diagnostics, opening up another new market for PCR-based tests.

Over time, many changes and improvements in PCR technology have been developed. One significant advance was the development of real-time PCR. With real-time PCR, detection of the amplicon occurs in real-time as the amplification reaction progresses, versus the initial PCR test technology method (traditional PCR), in which detection of amplified DNA product (amplicon) takes place at the end of the reaction (end-point PCR). Real-time PCR assays can be quantitative assays, measuring the initial number of copies of the target or template DNA that is present in a sample. Real-time PCR is typically referred to as qPCR, while the term " RT-PCR" is usually reserved for reverse transcriptase PCR, a method used to make a complementary DNA (cDNA) strand from RNA.

Digital PCR (dPCR) divides the reaction into smaller, discrete reactions, partitioning them so that individual nucleic acid molecules are localized and concentrated within numerous separate regions, be they in microplates, capillaries, arrays of miniaturized chambers, or water-oil emulsions (in a technique called droplet digital PCR, or ddPCR).

Key Topics Covered:

1. Executive Summary

• Nucleic Acid Amplification Testing Overview
• Scope and Methodology
• Market Overview
• Table Life Science PCR Market, Instruments versus Consumables, Worldwide, 2016 and 2021 (in millions USD)
• Future Prospects in the PCR Market

2. Introduction

• Development and Evolution of Polymerase Chain Reaction and Other Nucleic Acid Amplification Tests
• Development and Evolution of PCR
• Other Nucleic Acid Amplification Test Methods
• Advances in Nucleic Acid Amplification Technology and Emerging Applications
• Point-of-View

3. Technology Trends and Innovation

• Polymerase Chain Reaction (PCR) - Overview
• PCR, RT-PCR, and qPCR
• Digital PCR
• Multiplex PCR
• Other Modifications of PCR
• Other Nucleic Acid Amplification Test (PCR) Methods
• Platforms Used in Different PCR Markets - Research, Clinical Laboratories, and Point-of-Care Testing
• New Applications of PCR - Combining PCR with Other Technologies
• PCR as Part of Sample Prep before DNA Sequencing

4. Nucleic Acid Amplification Tests in Research

• Research Applications of Polymerase Chain Reaction
• Non-Clinical Applications of Polymerase Chain Reaction

5. Deals - Polymerase Chain Reaction/Nucleic Acid Amplification Test Companies

• Mergers and Acquisitions
• Corporate Agreements and Collaborations (Not Including Pharmaceutical Companies)
• Collaborations and Other Agreements with Universities, Non-Profit Research Institutes and Government

6. Market Drivers and Challenges - Nucleic Acid Amplification Test Market

• Issues and Hurdles Faced by PCR Companies Selling to the Life Science (Research) Market
• Competition from Companies Utilizing PCR and Other PCR Technologies
• Competition and Market Opportunities Driven by Other (non-PCR) Technologies
• Competition
• Opportunities
• Future Prospects

7. Polymerase Chain Reaction (PCR) and Nucleic Acid Amplification Test (PCR) Market Analysis

• Nucleic Acid Amplification Test Market Overview
• Life Science PCR Market
• Past and Future Growth of Overall Life Science PCR Market
• Life Science PCR Market - Instruments versus Consumables
• Life Science PCR Market - By Geographical Distribution
• Life Science PCR Market by Type of PCR
• dPCR
• qPCR
• Life Science PCR Market by Application
• General Medical/Disease Research
• Pharmaceutical Research

8. Company Profiles

• Agena Bioscience, Inc.
• Agilent Technologies Inc.
• AutoGenomics, Inc.
• BJS Biotehchnologies
• Bio-Rad Laboratories, Inc.
• BioGenex Laboratories, Inc.
• Bioneer Corporation
• Bruker Corporation
• Cole-Parmer (formerly Bibby Scientific)
• Denville Scientific, Inc.
• Enzo Life Sciences, Inc.
• Eppendorf AG
• Fluidigm Corporation
• Integrated DNA Technologies, Inc.
• LGC Douglas Scientific
• Lucigen Corporation
• Luminex Corporation
• Promega Corporation
• QIAGEN N.V.
• Takara Bio, Inc.
• Thermo Fisher Scientific, Inc.

For more information about this report visit https://www.researchandmarkets.com/research/dmrt9v/pcr_markets_for?w=12

CONTACT: ResearchAndMarkets.com
         Laura Wood, Senior Manager
         [email protected]
         For E.S.T Office Hours Call 1-917-300-0470
         For U.S./CAN Toll Free Call 1-800-526-8630
         For GMT Office Hours Call +353-1-416-8900
         Related Topics: Biotechnology, Molecular Diagnostics